Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 86, Issue 4, 2013, Pages 665-670

  Gomez, Daniel R ^a   Gillin, Michael ^a   Liao, Zhongxing ^a   Wei, Caimiao ^a   Lin, Steven H ^a   Swanick, Cameron ^a   Alvarado, Tina ^a   Komaki, Ritsuko ^a   Cox, James D ^a   Chang, Joe Y ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOID TUMORS; CONCURRENT CHEMOTHERAPY; DOSE LIMITING TOXICITY; MEDIASTINAL LYMPH NODES; METHODS AND MATERIALS; NON SMALL CELL LUNG CANCER; PROTON BEAM THERAPY; RELATIVE BIOLOGICAL EFFECTIVENESS;

BIOLOGICAL ORGANS; CHEMOTHERAPY; DISEASES; ENZYME INHIBITION; PROTON BEAMS; TUMORS;

PATIENT TREATMENT;

BEVACIZUMAB;

ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; CARCINOID; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MEDIASTINUM LYMPH NODE; METASTASIS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROTON RADIATION; PROTON THERAPY; RADIATION DOSE ESCALATION; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION PNEUMONIA; THYROID TUMOR; TRACHEOESOPHAGEAL FISTULA;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; ESOPHAGITIS; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPHATIC IRRADIATION; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; ORGANS AT RISK; PROSPECTIVE STUDIES; PROTON THERAPY; RADIATION PNEUMONITIS; RELATIVE BIOLOGICAL EFFECTIVENESS;

EID: 84879228546     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.03.035     Document Type: Article

References (20)

1. C.J. Langer, J. Manola, and P. Bernardo Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: Implications of Eastern Cooperative Oncology Group 5592, a randomized trial J Natl Cancer Inst 94 2002 173 181
2. C.P. Belani, and F. Fossella Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326) Cancer 104 2005 2766 2774
3. C.J. Sweeney, J. Zhu, and A.B. Sandler Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: A Phase II trial in patients with metastatic nonsmall cell lung carcinoma Cancer 92 2001 2639 2647
4. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
5. L.N. Nguyen, R. Komaki, and P. Allen Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review Int J Radiat Oncol Biol Phys 44 1999 1053 1056
6. A. Amini, S.H. Lin, and C. Wei Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer Radiat Oncol 7 2012 33
7. M. Engelsman, E. Rietzel, and H.M. Kooy Four-dimensional proton treatment planning for lung tumors Int J Radiat Oncol Biol Phys 64 2006 1589 1595
8. Y. Kang, X. Zhang, and J.Y. Chang 4D Proton treatment planning strategy for mobile lung tumors Int J Radiat Oncol Biol Phys 67 2007 906 914
9. M.F. Moyers, D.W. Miller, and D.A. Bush Methodologies and tools for proton beam design for lung tumors Int J Radiat Oncol Biol Phys 49 2001 1429 1438
10. Y. Ji, Y. Li, and B. Nebiyou Bekele Dose-finding in phase I clinical trials based on toxicity probability intervals Clin Trials 4 2007 235 244
11. J.B. Adkison, D. Khuntia, and S.M. Bentzen Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: Preliminary results of a risk-stratified phase I dose escalation study Technol Cancer Res Treat 7 2008 441 447
12. Z.F. Zhu, M. Fan, and K.L. Wu A phase II trial of accelerated hypofractionated three-dimensional conformal radiation therapy in locally advanced non-small cell lung cancer Radiother Oncol 98 2011 304 308
13. M.F. Osti, L. Agolli, and M. Valeriani Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer Int J Radiat Oncol Biol Phys 85 2013 e157 e163
14. J.F. Fowler 21 years of biologically effective dose Br J Radiol 83 2010 554 568
15. Z.X. Liao, R.R. Komaki, and H.D. Thames Jr. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy Int J Radiat Oncol Biol Phys 76 2010 775 781
16. K.E. Rosenzweig, J.L. Fox, and E. Yorke Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma Cancer 103 2005 2118 2127
17. B. Goodgame, N. Veeramachaneni, and A. Patterson Tracheo-esophageal fistula with bevacizumab after mediastinal radiation J Thorac Oncol 3 2008 1080 1081
18. E. Gore, A. Currey, and N. Choong Tracheoesophageal fistula associated with bevacizumab 21 months after completion of radiation therapy J Thorac Oncol 4 2009 1590 1591
19. D.R. Spigel, J.D. Hainsworth, and D.A. Yardley Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab J Clin Oncol 28 2010 43 48
20. M. Engelsman, M. Schwarz, and L. Dong Physics controversies in proton therapy Semin Radiat Oncol 23 2013 88 96